Aoki T, , Mizutani T, , Nojima K, , Takagi T, , Okumura R, & Yuba Y, et al.: Phase II study of ifosfamide, carboplatin, and etoposide in patients with a first recurrence of glioblastoma multiforme. Clinical article. J Neurosurg 112:50–56, 2010

Aoki T, Mizutani T, Nojima K, Takagi T, Okumura R, Yuba Y, : Phase II study of ifosfamide, carboplatin, and etoposide in patients with a first recurrence of glioblastoma multiforme. Clinical article. J Neurosurg 112:50–56, 2010)| false
• Search Google Scholar
• Export Citation

Bourgeois M, , Vinikoff L, , Lellouch-Tubiana A, & Sainte-Rose C: Reactivation of herpes virus after surgery for epilepsy in a pediatric patient with mesial temporal sclerosis: case report. Neurosurgery 44:633–636, 1999

Bourgeois M, Vinikoff L, Lellouch-Tubiana A, Sainte-Rose C: Reactivation of herpes virus after surgery for epilepsy in a pediatric patient with mesial temporal sclerosis: case report. Neurosurgery 44:633–636, 1999)| false
• Search Google Scholar
• Export Citation

Chamberlain MC: Recurrent chiasmatic-hypothalamic glioma treated with oral etoposide. Arch Neurol 52:509–513, 1995

Chamberlain MC: Recurrent chiasmatic-hypothalamic glioma treated with oral etoposide. Arch Neurol 52:509–513, 1995)| false
• Search Google Scholar
• Export Citation

Chamberlain MC: Recurrent supratentorial malignant gliomas in children. Long-term salvage therapy with oral etoposide. Arch Neurol 54:554–558, 1997

Chamberlain MC: Recurrent supratentorial malignant gliomas in children. Long-term salvage therapy with oral etoposide. Arch Neurol 54:554–558, 1997)| false
• Search Google Scholar
• Export Citation

de Jong MC, , Slootstra JW, , Scheffer GL, , Schroeijers AB, , Puijk WC, & Dinkelberg R, et al.: Peptide transport by the multidrug resistance protein MRP1. Cancer Res 61:2552–2557, 2001

de Jong MC, Slootstra JW, Scheffer GL, Schroeijers AB, Puijk WC, Dinkelberg R, : Peptide transport by the multidrug resistance protein MRP1. Cancer Res 61:2552–2557, 2001)| false
• Search Google Scholar
• Export Citation

Deorah S, , Lynch CF, , Sibenaller ZA, & Ryken TC: Trends in brain cancer incidence and survival in the United States: Surveillance, Epidemiology, and End Results Program, 1973 to 2001. Neurosurg Focus 20:4 E1, 2006

Deorah S, Lynch CF, Sibenaller ZA, Ryken TC: Trends in brain cancer incidence and survival in the United States: Surveillance, Epidemiology, and End Results Program, 1973 to 2001. Neurosurg Focus 20:4E1, 2006)| false
• Search Google Scholar
• Export Citation

Elad S, , Zadik Y, , Hewson I, , Hovan A, , Correa ME, & Logan R, et al.: A systematic review of viral infections associated with oral involvement in cancer patients: a spotlight on Herpesviridea. Support Care Cancer 18:993–1006, 2010

Elad S, Zadik Y, Hewson I, Hovan A, Correa ME, Logan R, : A systematic review of viral infections associated with oral involvement in cancer patients: a spotlight on Herpesviridea. Support Care Cancer 18:993–1006, 2010)| false
• Search Google Scholar
• Export Citation

Fulton D, , Urtasun R, & Forsyth P: Phase II study of prolonged oral therapy with etoposide (VP16) for patients with recurrent malignant glioma. J Neurooncol 27:149–155, 1996

Fulton D, Urtasun R, Forsyth P: Phase II study of prolonged oral therapy with etoposide (VP16) for patients with recurrent malignant glioma. J Neurooncol 27:149–155, 1996)| false
• Search Google Scholar
• Export Citation

Graber JJ, , Rosenblum MK, & DeAngelis LM: Herpes simplex encephalitis in patients with cancer. J Neurooncol 105:415–421, 2011

Graber JJ, Rosenblum MK, DeAngelis LM: Herpes simplex encephalitis in patients with cancer. J Neurooncol 105:415–421, 2011)| false
• Search Google Scholar
• Export Citation

Grewal J, , Dellinger CA, & Yung WK: Fatal reactivation of hepatitis B with temozolomide. N Engl J Med 356:1591–1592, 2007

Grewal J, Dellinger CA, Yung WK: Fatal reactivation of hepatitis B with temozolomide. N Engl J Med 356:1591–1592, 2007)| false
• Search Google Scholar
• Export Citation

Hjalmarsson A, , Blomqvist P, & Sköldenberg B: Herpes simplex encephalitis in Sweden, 1990-2001: incidence, morbidity, and mortality. Clin Infect Dis 45:875–880, 2007

Hjalmarsson A, Blomqvist P, Sköldenberg B: Herpes simplex encephalitis in Sweden, 1990-2001: incidence, morbidity, and mortality. Clin Infect Dis 45:875–880, 2007)| false
• Search Google Scholar
• Export Citation

Kocher M, , Kunze S, , Eich HT, , Semrau R, & Müller RP: Efficacy and toxicity of postoperative temozolomide radiochemotherapy in malignant glioma. Strahlenther Onkol 181:157–163, 2005

Kocher M, Kunze S, Eich HT, Semrau R, Müller RP: Efficacy and toxicity of postoperative temozolomide radiochemotherapy in malignant glioma. Strahlenther Onkol 181:157–163, 2005)| false
• Search Google Scholar
• Export Citation

Lins H, , Kanakis D, , Heinrichs T, , Dietzmann K, , Wallesch CW, & Mawrin C: Sudden progression of a glioblastoma in partial remission?. Clin Neurol Neurosurg 106:335–336, 2004

Lins H, Kanakis D, Heinrichs T, Dietzmann K, Wallesch CW, Mawrin C: Sudden progression of a glioblastoma in partial remission?. Clin Neurol Neurosurg 106:335–336, 2004)| false
• Search Google Scholar
• Export Citation

Markert JM, , Medlock MD, , Rabkin SD, , Gillespie GY, , Todo T, & Hunter WD, et al.: Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial. Gene Ther 7:867–874, 2000

Markert JM, Medlock MD, Rabkin SD, Gillespie GY, Todo T, Hunter WD, : Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial. Gene Ther 7:867–874, 2000)| false
• Search Google Scholar
• Export Citation

Matsumoto Y, , Tamiya T, & Nagao S: Resistance to topoisomerase II inhibitors in human glioma cell lines overexpressing multidrug resistant associated protein (MRP) 2. J Med Invest 52:41–48, 2005

Matsumoto Y, Tamiya T, Nagao S: Resistance to topoisomerase II inhibitors in human glioma cell lines overexpressing multidrug resistant associated protein (MRP) 2. J Med Invest 52:41–48, 2005)| false
• Search Google Scholar
• Export Citation

Meije Y, , Lizasoain M, , García-Reyne A, , Martínez P, , Rodríguez V, & López-Medrano F, et al.: Emergence of cytomegalovirus disease in patients receiving temozolomide: report of two cases and literature review. Clin Infect Dis 50:e73–e76, 2010

Meije Y, Lizasoain M, García-Reyne A, Martínez P, Rodríguez V, López-Medrano F, : Emergence of cytomegalovirus disease in patients receiving temozolomide: report of two cases and literature review. Clin Infect Dis 50:e73–e76, 2010)| false
• Search Google Scholar
• Export Citation

Mineta T, , Rabkin SD, , Yazaki T, , Hunter WD, & Martuza RL: Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas. Nat Med 1:938–943, 1995

Mineta T, Rabkin SD, Yazaki T, Hunter WD, Martuza RL: Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas. Nat Med 1:938–943, 1995)| false
• Search Google Scholar
• Export Citation

Orlowski RZ, , Mills SR, , Hartley EE, , Ye X, , Piantadosi S, & Ambinder RF, et al.: Oral valacyclovir as prophylaxis against herpes simplex virus reactivation during high dose chemotherapy for leukemia. Leuk Lymphoma 45:2215–2219, 2004

Orlowski RZ, Mills SR, Hartley EE, Ye X, Piantadosi S, Ambinder RF, : Oral valacyclovir as prophylaxis against herpes simplex virus reactivation during high dose chemotherapy for leukemia. Leuk Lymphoma 45:2215–2219, 2004)| false
• Search Google Scholar
• Export Citation

Reardon DA, , Desjardins A, , Peters K, , Gururangan S, , Sampson J, & Rich JN, et al.: Phase II study of metronomic chemotherapy with bevacizumab for recurrent glioblastoma after progression on bevacizumab therapy. J Neurooncol 103:371–379, 2011

Reardon DA, Desjardins A, Peters K, Gururangan S, Sampson J, Rich JN, : Phase II study of metronomic chemotherapy with bevacizumab for recurrent glioblastoma after progression on bevacizumab therapy. J Neurooncol 103:371–379, 2011)| false
• Search Google Scholar
• Export Citation

Riel-Romero RM, & Baumann RJ: Herpes simplex encephalitis and radiotherapy. Pediatr Neurol 29:69–71, 2003

Riel-Romero RM, Baumann RJ: Herpes simplex encephalitis and radiotherapy. Pediatr Neurol 29:69–71, 2003)| false
• Search Google Scholar
• Export Citation

Schäfer N, , Tichy J, , Thanendrarajan S, , Kim Y, , Stuplich M, & Mack F, et al.: Ifosfamide, carboplatin and etoposide in recurrent malignant glioma. Oncology 80:330–332, 2011

Schäfer N, Tichy J, Thanendrarajan S, Kim Y, Stuplich M, Mack F, : Ifosfamide, carboplatin and etoposide in recurrent malignant glioma. Oncology 80:330–332, 2011)| false
• Search Google Scholar
• Export Citation

Schiff D, & Rosenblum MK: Herpes simplex encephalitis (HSE) and the immunocompromised: a clinical and autopsy study of HSE in the settings of cancer and human immunodeficiency virus-type 1 infection. Hum Pathol 29:215–222, 1998

Schiff D, Rosenblum MK: Herpes simplex encephalitis (HSE) and the immunocompromised: a clinical and autopsy study of HSE in the settings of cancer and human immunodeficiency virus-type 1 infection. Hum Pathol 29:215–222, 1998)| false
• Search Google Scholar
• Export Citation

Schwarzberg AB, , Stover EH, , Sengupta T, , Michelini A, , Vincitore M, & Baden LR, et al.: Selective lymphopenia and opportunistic infections in neuroendocrine tumor patients receiving temozolomide. Cancer Invest 25:249–255, 2007

Schwarzberg AB, Stover EH, Sengupta T, Michelini A, Vincitore M, Baden LR, : Selective lymphopenia and opportunistic infections in neuroendocrine tumor patients receiving temozolomide. Cancer Invest 25:249–255, 2007)| false
• Search Google Scholar
• Export Citation

Sevim H, , Parkinson JF, & McDonald KL: Etoposide-mediated glioblastoma cell death: dependent or independent on the expression of its target, topoisomerase II alpha?. J Cancer Res Clin Oncol 137:1705–1712, 2011

Sevim H, Parkinson JF, McDonald KL: Etoposide-mediated glioblastoma cell death: dependent or independent on the expression of its target, topoisomerase II alpha?. J Cancer Res Clin Oncol 137:1705–1712, 2011)| false
• Search Google Scholar
• Export Citation

Spacca B, , Mallucci C, , Riordan A, , Appleton R, , Thorp N, & Pizer B: HSV encephalitis in a child with brain stem glioma: a rare complication of therapy. Case report and review of the neurosurgical literature. Childs Nerv Syst 23:1347–1350, 2007

Spacca B, Mallucci C, Riordan A, Appleton R, Thorp N, Pizer B: HSV encephalitis in a child with brain stem glioma: a rare complication of therapy. Case report and review of the neurosurgical literature. Childs Nerv Syst 23:1347–1350, 2007)| false
• Search Google Scholar
• Export Citation

Spuler A, , Blaszyk H, , Parisi JE, & Davis DH: Herpes simplex encephalitis after brain surgery: case report and review of the literature. J Neurol Neurosurg Psychiatry 67:239–242, 1999

Spuler A, Blaszyk H, Parisi JE, Davis DH: Herpes simplex encephalitis after brain surgery: case report and review of the literature. J Neurol Neurosurg Psychiatry 67:239–242, 1999)| false
• Search Google Scholar
• Export Citation

van den Bent MJ, , Pronk L, , Sillevis Smitt PA, , Vecht CJ, , Eskens FA, & Verweij J: Phase II study of weekly dose-intensified cisplatin chemotherapy with oral etoposide in recurrent glioma. J Neurooncol 44:59–64, 1999

van den Bent MJ, Pronk L, Sillevis Smitt PA, Vecht CJ, Eskens FA, Verweij J: Phase II study of weekly dose-intensified cisplatin chemotherapy with oral etoposide in recurrent glioma. J Neurooncol 44:59–64, 1999)| false
• Search Google Scholar
• Export Citation